This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Lucas Siow
CEO and Co-Founder at ProteinQure
Speaker

Profile

Lucas is the CEO and one of the co-founders of ProteinQure. ProteinQure is a eclinical stage biotech based in downtown Toronto. ProteinQure is the only computational platform combining AI and molecular dynamics to design exotic peptides and their conjugates. They have worked with four of the top 25 pharma companies in the world, and over 8500 non-natural building blocks on their platform. They utilize non-canonical amino acids and complex scaffolds to engineer peptides for potency, stability, specificity and other drug like properties. Their lead program is in phase I for TNBC.

Agenda Sessions

  • siRNA CNS Delivery Using Peptide Ligands and Preclinical Development

    , 9:30am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Lucas at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now